LT - 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes
EN - 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 223/16 |
(2006.01) |
|
|
A61K 31/55 |
(2006.01) |
|
|
A61P 3/00 |
(2006.01) |
|
|
A61P 9/00 |
(2006.01) |
|
|
A61P 25/00 |
(2006.01) |
|
|
C07D 403/04 |
(2006.01) |
|
|
C07D 409/04 |
(2006.01) |
|
|
C07D 491/04 |
(2006.01) |
|
|
A61K 9/20 |
(2006.01) |
European patent
| (11) |
Number of the document |
2374796 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
10010297.9 |
|
Date of filing the European patent application |
2003-04-11 |
| (97) |
Date of publication of the European application |
2011-10-12 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-02-28
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
372058 P |
2002-04-12
|
US |
|
405495 P |
2002-08-23
|
US |
|
434607 P |
2002-12-18
|
US |
|
410991 |
2003-04-10
|
US |
Inventors
| (72) |
Smith, Jeffrey, US
Smith, Brian, US
|
Grantee
| (73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
Title
| (54) |
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes |
| |
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes |
